gefitinib has been researched along with 6-aminonicotinamide in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (6-aminonicotinamide) | Trials (6-aminonicotinamide) | Recent Studies (post-2010) (6-aminonicotinamide) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 342 | 1 | 35 |
| Protein | Taxonomy | gefitinib (IC50) | 6-aminonicotinamide (IC50) |
|---|---|---|---|
| Nicotinamide N-methyltransferase | Homo sapiens (human) | 3.62 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Chen, G; Chen, Y; Ding, J; Huang, R; Ji, D; Song, B; Yuan, L | 1 |
1 other study(ies) available for gefitinib and 6-aminonicotinamide
| Article | Year |
|---|---|
Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway.
Topics: 6-Aminonicotinamide; Afatinib; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; ErbB Receptors; Gefitinib; Glucose; Humans; Metabolome; Multiple Myeloma; Oxygen; Pentose Phosphate Pathway; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Quinazolines; ras Proteins; Receptor, ErbB-2; RNA, Small Interfering; TOR Serine-Threonine Kinases | 2015 |